Microsoft (NASDAQ:MSFT) Earns Buy (B) Rating from Weiss Ratings
Weiss Ratings reissued a “buy (b)” rating on shares of Microsoft in a research report on Saturday.
Source link
Weiss Ratings reissued a “buy (b)” rating on shares of Microsoft in a research report on Saturday.
Source link
By Michelle Conlin and Matt Tracy NEW YORK/WASHINGTON (Reuters) – For 32 years, Jim Tynan had a homeowners’ policy with Allstate (NYSE:) on his 1,200-square foot condo in Ponte Vedra, Florida. In January, Tynan’s Allstate subsidiary told him it was going to drop him. Tynan called ten different agencies, “and none would cover me,” he…
This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston BioHealth. The group is for both novice and experienced biotech investors. It provides catalysts to…
May 20, 2025May 20, 2025 Putin continues to push for a peace deal on his terms while still advancing militarily in Ukraine, resisting international pressure for a cease-fire before talks. Trump’s recent call with Putin marked a shift, as he welcomed direct talks between Russia…
I’m in Melbourne this week for the Bullion & Bordeaux Hour. (Curious? Find out more here.) And to farewell my colleague, Callum Newman. It’s mid-September 2025 already. I reflect on the same time in 2022 and 2023. How much things have changed for precious metals! If you’re not aware, gold and silver have been on…
Welcome to the Artificial Intelligence Outlook for Forex trading. VIDEO TRANSCRIPT Okay, hello everyone and welcome back. My name is Greg Firman, and this is the Vantage Point AI market outlook for the week of August the 4th, 2025. Now, to get started this week, we’re going to change things up a little bit for…
April 1, 2026April 1, 2026 Shares of Marksans Pharma Ltd skyrocketed 9% on 1 April after the firm announced that its Benzonatate Capsules had received approval from the US Food and Drug Administration (USFDA). The firm announced that it had acquired final approval from the US Food and Drug…